Market Cap 122.60M
Revenue (ttm) 53.40M
Net Income (ttm) 2.93M
EPS (ttm) N/A
PE Ratio 37.50
Forward PE 8.56
Profit Margin 5.49%
Debt to Equity Ratio 0.00
Volume 609,196
Avg Vol 1,231,672
Day's Range N/A - N/A
Shares Out 79.61M
Stochastic %K 63%
Beta -0.23
Analysts Strong Sell
Price Target $14.00

Company Profile

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 696 9345
Address:
2 University Plaza, Suite 100, Hackensack, United States
charleston_invest
charleston_invest Jul. 7 at 6:42 PM
$PLX The only reason this stock is where it is, is because no one has faith in PLX's management team. They have consistently shown that they have zero regard for the stockholder or the share price of the stock. Everyone at the moment fears that management has once again sold out the stockholders and sold a decent amount of ATM (at the worst possible time - when demand should have increased stock value)- when they publicly stated that they had absolutely no need to do so and were not planning to do so. They said they had ample capital runway for the journey forward. Since they never disclose anything, we have to wait to see the next ER for the truth to come out. Don't give me that managements hands are tied with their contracts with Chiesi - telling the public that they have not issued any new ATM is well within their power which would boost this stock immediately - except of course if that was not the case.
1 · Reply
OldManLogan
OldManLogan Jul. 7 at 6:00 PM
$PLX Ya... that makes sense... given that both PLX and RIVN have $15 price targets but RIVN is already trading at nearly 10x higher share price than PLX... also PLX expected to earn 40c in EPS next year ... while RIVN is not expected to earn anything until 2030...
1 · Reply
BryGuy29
BryGuy29 Jul. 7 at 4:54 PM
$PLX started to scale out today, sold some. Adding more RIVN instead. I’ve waited too long here, wasted time. Time to move on. Hey, on the bright side, stocks usually go UP when I sell…. So, you’re welcome 😂
1 · Reply
zoomlik
zoomlik Jul. 7 at 4:47 PM
$PLX P/e 35 on 2027 EPS is min for this stage company.
0 · Reply
flyinghollaender
flyinghollaender Jul. 7 at 4:12 PM
0 · Reply
Artfldgr
Artfldgr Jul. 7 at 3:09 PM
$PLX Funny how economists claim to understand markets, yet the median salary is ~$113K, and almost none become wealthy from their predictions. Name one billionaire economist—hard to do. Even Nobel winners like Paul Krugman never cracked 7 figures from investing. If their models worked, they’d be on the Forbes list, not faculty rosters.
1 · Reply
pietro23
pietro23 Jul. 7 at 2:26 PM
1 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:58 PM
$PLX Strategic Interpretation These are not passive index funds blindly holding. They are event-aware, valuation-sensitive, and capable of applying internal and market pressure. Their presence raises the cost of misbehavior by Dror—especially now that PLX is in the Russell 3000, increasing visibility. Retailers with 500K+ shares can combine into a powerful informal voting bloc. While they can’t file 13D or 13G, they can escalate to media, analysts, and regulators, especially if collusion or stealth dilution is suspected. Dror’s 3.7% is vulnerable. Most of that was granted, not earned. If his stewardship causes harm, he can be marginalized with enough push. Key Risks for Dror: Whistleblower pressure is real and increasing Tutes will not allow unforced dilution just before catalysts Retail control of float is stronger than usual for a small-cap biotech Elze likely won’t cover for poor governance — he's a strategic asset, not a buffer
0 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:49 PM
1 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:44 PM
$PLX sec filing over holiday https://ir.protalix.com/static-files/25730e7f-ee37-425b-8fd4-88ad29c06a5b i saw no announcement... No public disclosure or press release means this was intentionally low-profile. Form was signed by Joseph Magnas (legal counsel) — not Dror, despite Dror being named in the Power of Attorney. This setup may allow future Form 4 filings to show granted shares or options — especially if an ATM run is used to “fund” equity comp. This was filed just before/after Russell 3000 confirmation — very sensitive timing. Not good if they did ATM to fund this, again, robbing retailers and treating them as a piggy bank without regard. Something is up and something smells... but i dont know if its roses or Shakespearian shit
0 · Reply
Latest News on PLX
Protalix BioTherapeutics Issues 2025 Letter to Stockholders

Dec 23, 2024, 6:50 AM EST - 7 months ago

Protalix BioTherapeutics Issues 2025 Letter to Stockholders


Protalix BioTherapeutics Issues 2024 Letter to Stockholders

Dec 26, 2023, 6:50 AM EST - 1 year ago

Protalix BioTherapeutics Issues 2024 Letter to Stockholders


Protalix BioTherapeutics Issues Letter to Stockholders

May 30, 2023, 6:50 AM EDT - 2 years ago

Protalix BioTherapeutics Issues Letter to Stockholders


charleston_invest
charleston_invest Jul. 7 at 6:42 PM
$PLX The only reason this stock is where it is, is because no one has faith in PLX's management team. They have consistently shown that they have zero regard for the stockholder or the share price of the stock. Everyone at the moment fears that management has once again sold out the stockholders and sold a decent amount of ATM (at the worst possible time - when demand should have increased stock value)- when they publicly stated that they had absolutely no need to do so and were not planning to do so. They said they had ample capital runway for the journey forward. Since they never disclose anything, we have to wait to see the next ER for the truth to come out. Don't give me that managements hands are tied with their contracts with Chiesi - telling the public that they have not issued any new ATM is well within their power which would boost this stock immediately - except of course if that was not the case.
1 · Reply
OldManLogan
OldManLogan Jul. 7 at 6:00 PM
$PLX Ya... that makes sense... given that both PLX and RIVN have $15 price targets but RIVN is already trading at nearly 10x higher share price than PLX... also PLX expected to earn 40c in EPS next year ... while RIVN is not expected to earn anything until 2030...
1 · Reply
BryGuy29
BryGuy29 Jul. 7 at 4:54 PM
$PLX started to scale out today, sold some. Adding more RIVN instead. I’ve waited too long here, wasted time. Time to move on. Hey, on the bright side, stocks usually go UP when I sell…. So, you’re welcome 😂
1 · Reply
zoomlik
zoomlik Jul. 7 at 4:47 PM
$PLX P/e 35 on 2027 EPS is min for this stage company.
0 · Reply
flyinghollaender
flyinghollaender Jul. 7 at 4:12 PM
0 · Reply
Artfldgr
Artfldgr Jul. 7 at 3:09 PM
$PLX Funny how economists claim to understand markets, yet the median salary is ~$113K, and almost none become wealthy from their predictions. Name one billionaire economist—hard to do. Even Nobel winners like Paul Krugman never cracked 7 figures from investing. If their models worked, they’d be on the Forbes list, not faculty rosters.
1 · Reply
pietro23
pietro23 Jul. 7 at 2:26 PM
1 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:58 PM
$PLX Strategic Interpretation These are not passive index funds blindly holding. They are event-aware, valuation-sensitive, and capable of applying internal and market pressure. Their presence raises the cost of misbehavior by Dror—especially now that PLX is in the Russell 3000, increasing visibility. Retailers with 500K+ shares can combine into a powerful informal voting bloc. While they can’t file 13D or 13G, they can escalate to media, analysts, and regulators, especially if collusion or stealth dilution is suspected. Dror’s 3.7% is vulnerable. Most of that was granted, not earned. If his stewardship causes harm, he can be marginalized with enough push. Key Risks for Dror: Whistleblower pressure is real and increasing Tutes will not allow unforced dilution just before catalysts Retail control of float is stronger than usual for a small-cap biotech Elze likely won’t cover for poor governance — he's a strategic asset, not a buffer
0 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:49 PM
1 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:44 PM
$PLX sec filing over holiday https://ir.protalix.com/static-files/25730e7f-ee37-425b-8fd4-88ad29c06a5b i saw no announcement... No public disclosure or press release means this was intentionally low-profile. Form was signed by Joseph Magnas (legal counsel) — not Dror, despite Dror being named in the Power of Attorney. This setup may allow future Form 4 filings to show granted shares or options — especially if an ATM run is used to “fund” equity comp. This was filed just before/after Russell 3000 confirmation — very sensitive timing. Not good if they did ATM to fund this, again, robbing retailers and treating them as a piggy bank without regard. Something is up and something smells... but i dont know if its roses or Shakespearian shit
0 · Reply
Wanl4756
Wanl4756 Jul. 7 at 1:37 PM
$PLX I still can't see anywhere that they are searching for a CFO to replace Eyal. If they are working with a recruitment company, would they be forced to publish that info because public trading?
1 · Reply
ed29
ed29 Jul. 7 at 1:32 PM
$PLX 27 min of Mr. Elze's viewpoints https://www.youtube.com/watch?v=We59Zsenkp0
0 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:30 PM
$PLX Automatic institutional buying: Index funds that track the Russell 3000 are now required to buy PLX. The Russell 3000 addition creates forced institutional demand — index funds must buy PLX shares, regardless of price. This should naturally drive the stock upward as supply tightens. But if Dror runs the ATM now, dumping shares into that demand, he's not just diluting — he's handing discounted shares to institutions at the exact moment they’re forced to buy. That’s: A transfer of value away from retail, who held through risk A breach of fiduciary duty, especially since PLX has no urgent need for cash A red flag to regulators, particularly if the company doesn’t disclose ATM activity during material events Retail held through all the risk—dumping into index demand to benefit tutes isn't just unfair, it's legally questionable.
1 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:24 PM
0 · Reply
Artfldgr
Artfldgr Jul. 7 at 1:21 PM
$PLX according to the news, PLX is now on Russel 2000 AND 3000 (added Jun 27th)
0 · Reply
OldManLogan
OldManLogan Jul. 7 at 12:40 PM
$PLX I'm not sure why he would want to spend money to acquire other assets when the real leverage is using ProCelleX platform to basically take existing drugs and make them more efficacious with fewer side effects... I guess it could happen eventually, but by then it should be funded out of profits... though I doubt Chiesi gives them the time to develop to that point...
2 · Reply
zoomlik
zoomlik Jul. 7 at 11:45 AM
$PLX Low estimate next year is 40 cents EPS We are trading at p/e of 4 with clean capital structure and no debt
2 · Reply
Artfldgr
Artfldgr Jul. 7 at 11:31 AM
$PLX Today may be interesting... (or not)... but its the first day with the news Christian is now on board... and he isnt going to want to be a long term prospect, given he makes infinitely more moolah if he floats from place to place. he also has experience with Sanofi.
1 · Reply
PRX102
PRX102 Jul. 6 at 11:50 PM
$PLX How bad could the dilution get if Dror wanted to acquire assets in other rare diseases, and rapidly expand pipeline?
3 · Reply
jcon777
jcon777 Jul. 6 at 11:37 PM
$PLX This page was updated July 3rd, and shows Zack's earnings estimates: current qtr: .03 next qtr: .07 current year: .18 next year: .60 https://www.zacks.com/stock/quote/PLX/detailed-earning-estimates
2 · Reply
kbf1
kbf1 Jul. 6 at 9:40 PM
$PLX I just glanced at this trending and almost had a heart attack before I realized it was some crypto coin 😵‍💫
0 · Reply
Social_Idiot
Social_Idiot Jul. 6 at 3:51 PM
$PLX I had a dream last night and PLX showed green ⬆️$1.00. Then I woke up depressed.
4 · Reply